EUVIMEDEUVIMED entdecken
Crossref

Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?

Neal Bhutiani, Mahmoud Mg Yousef, Abdelrahman Mg Yousef, Emaan U Haque, George J Chang, Tsuyoshi Konishi, Brian K Bednarski, Y Nancy You, John Paul Shen, Abhineet Uppal

Clinical Colorectal Cancer · 2025

DOI: 10.1016/j.clcc.2025.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2025. Verfasst von Neal Bhutiani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgery, Division of Surgical O…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Adenocarcinoma, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Extramural vascular invasion (EMVI) is associated with distant recurrence after treatment of locogionally advanced rectal adenocarcinomas (LARCs), but its use as a marker for response to neoadjuvant therapy is less well understood. We examined the relationship between EMVI and tumor or nodal category downstaging after treatment of LARCs with neoadjuvant therapy. METHODS: Patients with EMVI categorized on initial staging pelvic MRI for LARC who underwent curative-intent surgery after neoadjuvant therapy at MD Anderson Cancer Center from 2016 to 2022 were identified. Patients received either preoperative chemoradiation or total neoadjuvant therapy (TNT). Associations between EMVI and demographic, radiologic, and clinicopathologic variables were analyzed. RESULTS: EMVI was associated with higher rates of lymphovascular invasion (LVI) (46.2% vs. 27.8%, P = .001) and perineural invasion (PNI) (51.9% vs. 28.4%, P < .001) on final pathology. Patients with EMVI were more likely to have cT4 tumors (31.7% vs. 16.3%, P = .004) and cN+ status (86.8% vs. 66.3%, P = .001) and more likely to be treated with TNT rather than chemoradiation alone (62.3% vs. 41.9%, P = .005). EMVI was associated with a lower rate of pathologic complete or near-complete response (20.1% vs. 34.2%, P = .018), downstaging to ypT0-2 from cT3/4 tumors (14.9% vs. 44.4%, P = .0001), and downstaging to ypN0 from cN+ status (47.9% vs. 66.4%, P = .015). CONCLUSIONS: Rectal tumors with EMVI are more likely to have higher clinical stage, less likely to respond to neoadjuvant therapy despite increased use of TNT, and more likely to have high-risk features for recurrence. This suggests EMVI is a marker of disease with poorer response to neoadjuvant therapy. Disease biology should be strongly considered in treatment decision-making, and new treatment strategies are needed to improve disease response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyAdenocarcinomaNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedNeoplasm InvasivenessAgedNeoplasm StagingRetrospective StudiesChemoradiotherapy, AdjuvantMagnetic Resonance ImagingAdultRectum

Autor:innen und Institutionen

  • Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgery, Division of Surgical Oncology, University of Louisville School of Medicine, Louisville, KY.
  • Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgery, Division of Colon and Rectal Surgery, Emory University School of Medicine, Atlanta, GA. Elec…

Zitieren

APA

Bhutiani, N., Yousef, M. M., Yousef, A. M., Haque, E. U., Chang, G. J., Konishi, T., Bednarski, B. K., You, Y. N., Shen, J. P., & Uppal, A. (2025). Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2025.02.002

Vancouver

Bhutiani N, Yousef MM, Yousef AM, Haque EU, Chang GJ, Konishi T, et al. Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?. Clinical Colorectal Cancer. 2025. doi:10.1016/j.clcc.2025.02.002

BibTeX
@article{Bhutiani2025,
  author = {Bhutiani, Neal and Yousef, Mahmoud Mg and Yousef, Abdelrahman Mg and Haque, Emaan U and Chang, George J and Konishi, Tsuyoshi and Bednarski, Brian K and You, Y Nancy and Shen, John Paul and Uppal, Abhineet},
  title = {Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?},
  journal = {Clinical Colorectal Cancer},
  year = {2025},
  doi = {10.1016/j.clcc.2025.02.002}
}
Kostenlos starten →